In this community, professionals share information regarding the clinical, programmatic and community-oriented aspects of early diagnosis, treatment and prevention of multi-drug-resistant tuberculosis (MDR-TB). Members also use this forum to promote universal access to quality care for MDR-TB.
MTB DR SL version one tests for FLQ, Injectables and Ethambutol Does not differentiate resistance among the second line injectables only include gyrA for fluoroquinolone resistance less sensitive and specific than the version 2 MTB DR SL include gyrA and gyrB for fluoroquinolone resistance ethambutol is excluded included the eis ... read more
All, Please distribute to your networks and consider signing the letter below to ViiV regarding the availability of its pediatric formulation of dolutegravir (DTG). At issue: 1) ViiV refuses to sell pediatric DTG to countries, including with a standard waiver, unless the drugs are registered, but then drags its feet ... read more
Malawi-Liverpool-Wellcome Trust Clinical Research ProgrammeWork Locations
Ministry of Health, ZambiaWork Locations
General HospitalWork Locations